Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,325,022
-
Share change
-
-5,025,560
-
Total reported value
-
$19,197,063
-
Put/Call ratio
-
18%
-
Price per share
-
$1.86
-
Number of holders
-
67
-
Value change
-
-$30,423,966
-
Number of buys
-
28
-
Number of sells
-
31
Institutional Holders of AEVI GENOMIC MEDICINE INC - COM (GNMX) as of Q1 2017
As of 31 Mar 2017,
AEVI GENOMIC MEDICINE INC - COM (GNMX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,325,022 shares.
The largest 10 holders included
BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Opaleye Management Inc., SPHERA FUNDS MANAGEMENT LTD., STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.